Enhabit Inc
(NYSE:EHAB)
$
8.27
-0.06 (-0.72%)
Market Cap: 415.84 Mil
Enterprise Value: 981.36 Mil
PE Ratio: 0
PB Ratio: 0.62
GF Score: 25/100 - Q2 2024 Enhabit Inc Earnings Call TranscriptAug 07, 2024$8.5 (-14.05%)Earnings
- Q4 2023 Enhabit Inc Earnings Call TranscriptMar 07, 2024$9.6 (+22.14%)Earnings
- Q3 2023 Enhabit Inc Earnings Call TranscriptNov 08, 2023$9.92 (+16.02%)Earnings
- Q2 2023 Enhabit Inc Earnings Call TranscriptAug 10, 2023$11.81 (-13.80%)Earnings
- Enhabit Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 Enhabit Inc Earnings Call TranscriptMay 10, 2023$12.33 (-8.73%)Earnings
- Enhabit Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 14, 2023
- Enhabit Inc at Citi Healthcare & Medtech Conference TranscriptMar 01, 2023
- Q4 2022 Enhabit Inc Earnings Call TranscriptFeb 15, 2023$15.99 (+12.37%)Earnings
- Enhabit Inc at CJS Securities New Ideas for the New Year Investor Conference (Virtual) TranscriptJan 11, 2023
Enhabit Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 14, 2023 / 04:40PM GMT
Release Date Price:
$14.36
(+2.57%)
Michael David Wiederhorn
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst
Good afternoon. And welcome to Oppenheimer's 33rd Annual Healthcare Conference. I'm Michael Wiederhorn, the health care services analyst. It's my pleasure today to have Enhabit Home Health & Hospice. We have Chief Executive Officer, Barbara Jacobsmeyer; and Chief Financial Officer, Crissy Carlisle. Thank you guys for joining us.
Barbara Ann Jacobsmeyer
Enhabit, Inc. - President, CEO & Director
Thank you.
Crissy Buchanan Carlisle
Enhabit, Inc. - CFO
Thank you.
Michael David Wiederhorn
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst
Today, we'll do a fireside. So we'll keep this pretty informal. And hopefully, you guys will get a lot out of this.
Questions & Answers
Michael David Wiederhorn
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst
So we'll start with the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)